![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TYW1B |
Gene summary for TYW1B |
![]() |
Gene information | Species | Human | Gene symbol | TYW1B | Gene ID | 441250 |
Gene name | tRNA-yW synthesizing protein 1 homolog B | |
Gene Alias | LINC00069 | |
Cytomap | 7q11.22-q11.23 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | A0A087WZB2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
441250 | TYW1B | CCI_1 | Human | Cervix | CC | 9.97e-06 | 4.46e-01 | 0.528 |
441250 | TYW1B | CCI_2 | Human | Cervix | CC | 2.97e-13 | 1.11e+00 | 0.5249 |
441250 | TYW1B | CCI_3 | Human | Cervix | CC | 4.04e-10 | 6.07e-01 | 0.516 |
441250 | TYW1B | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.48e-03 | 4.72e-01 | 0.343 |
441250 | TYW1B | RNA-P17T-P17T-8 | Human | Lung | IAC | 4.12e-03 | 3.97e-01 | 0.3329 |
441250 | TYW1B | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 8.87e-03 | 2.10e-01 | -0.2116 |
441250 | TYW1B | RNA-P25T1-P25T1-3 | Human | Lung | AIS | 9.09e-03 | 3.44e-01 | -0.2107 |
441250 | TYW1B | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 2.98e-05 | 3.14e-01 | -0.2119 |
441250 | TYW1B | RNA-P3T-P3T-1 | Human | Lung | IAC | 1.03e-03 | 3.42e-01 | 0.1829 |
441250 | TYW1B | RNA-P3T-P3T-4 | Human | Lung | IAC | 1.67e-02 | 2.60e-01 | 0.1859 |
441250 | TYW1B | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 4.64e-16 | 5.13e-01 | -0.0166 |
441250 | TYW1B | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 5.68e-19 | 5.56e-01 | -0.0132 |
441250 | TYW1B | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 5.10e-22 | 5.96e-01 | -0.013 |
441250 | TYW1B | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 6.93e-13 | 4.42e-01 | -0.0121 |
441250 | TYW1B | RNA-P7T1-P7T1-1 | Human | Lung | AIS | 2.37e-02 | 2.98e-01 | -0.0961 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TYW1B | SNV | Missense_Mutation | novel | c.1013A>T | p.Asn338Ile | p.N338I | protein_coding | deleterious(0) | benign(0.017) | TCGA-D1-A160-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | rs782217657 | c.298N>A | p.Glu100Lys | p.E100K | protein_coding | tolerated(0.1) | probably_damaging(0.937) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | novel | c.1759A>C | p.Asn587His | p.N587H | protein_coding | deleterious(0.04) | probably_damaging(0.981) | TCGA-DF-A2KV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | novel | c.1718N>C | p.Leu573Pro | p.L573P | protein_coding | tolerated(0.09) | possibly_damaging(0.808) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD | |
TYW1B | SNV | Missense_Mutation | novel | c.855N>T | p.Lys285Asn | p.K285N | protein_coding | tolerated(0.23) | benign(0.007) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | novel | c.309G>C | p.Glu103Asp | p.E103D | protein_coding | tolerated(0.29) | benign(0.026) | TCGA-E6-A2P9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | rs368655650 | c.1574N>T | p.Ala525Val | p.A525V | protein_coding | tolerated(0.17) | possibly_damaging(0.746) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | novel | c.1609N>A | p.Glu537Lys | p.E537K | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response | |
TYW1B | SNV | Missense_Mutation | novel | c.1609G>A | p.Glu537Lys | p.E537K | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TYW1B | SNV | Missense_Mutation | novel | c.622G>A | p.Gly208Ser | p.G208S | protein_coding | tolerated(0.21) | benign(0.097) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |